Back

Metoprolol succinate efficacy in patients with chronic heart failure on the background of obesity: genetic aspects of individual sensitivity and tolerability

31 August 2019 (11:00 - 16:00)
Organised by:
Congress Presentation Part of: Poster Session 1 - Heart failure management Pharmacotherapy ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Iurii Rudyk

L.T.Malaya Institute of Therapy, Kharkiv (Ukraine)

9 More presentations in this session

Presentation thumbnail
Doctor D. Matan (Stockholm, SE)
Abstract
Presentation thumbnail
Doctor C. Madelaire (Odense, DK)
Abstract
Presentation thumbnail
Doctor J. Graby (Bristol, GB)
Abstract Slides
Presentation thumbnail
Doctor E. Nakai (Suita, JP)
Abstract Slides
Presentation thumbnail
Doctor K. Kawashima (Obu, JP)
Abstract

Access the full session

Session thumbnail
Poster Session 1 - Heart failure management

The Event

Event poster

ESC Congress 2019

31 August 2019 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Clinical effects of metoprolol in obstructive hypertrophic cardiomyopathy (TEMPO). A randomized, double-blinded, placebo-controlled crossover trial
27 August 2021
thumbnail
Congress Presentation
The association of Beta-adrenoreception system genes polymorphisms and interleukins levels in patients with heart failure
29 June 2021
thumbnail
Congress Presentation
Effect of obesity on the implementation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction
18 May 2025
thumbnail
Congress Presentation
Drug related metabolites and genetic polymorphisms predict low low-density lipoprotein cholesterol response to atorvastatin treatment in patients with coronary heart disease
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources